• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MENAQUINONE 4
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION & THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ADROPIN
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • ADDICTION & DOPAMINE
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • ANXIOLYTIC
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BIOMIMETIC HYDROXYAPATITE
      • BMI-1
      • BPA & OBESITY
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CDK5
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DEPERSONALIZATION
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENDOCRINE DISRUPTING CHEMICALS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING & THE BRAIN
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUCOCORTICOID RECEPTOR ACTIVATION
      • GLUTAMATE & BRAIN
      • GLYCATION
      • GUT BRAIN AXIS
      • KLOTHO
      • K OPIOD RECEPTOR & ADDICTION
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HAIR REPIGMENTATION
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERALGESIA
      • HYPERINSULINEMIA
      • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INSULIN OXIDATIVE STRESS
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR & FEAR
      • NON OPIOD ANALGESICS
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • OBESOGENS
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SEX HORMONE BINDING GLOBULIN
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • THROMBOLYTICS (PLANT BASED)
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
      • XENOBIOTICS
      • XENOESTROGEN
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    RED WINE
    March 5, 2022
    MUSCLE FORCE PRODUCTION
    March 5, 2022
    1. Noradrenergic projections to the spinal cord of the rat
    2. The immune response evokes changes in brain Noradrenergic neurons
    3. Overeating and obesity from damage to a Noradrenergic system in the brain
    4. Spinal Noradrenergic terminal system mediates antinociception
    5. Central Noradrenergic regulation of cerebral blood flow and vascular permeability
    6. Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization
    7. The organization of Noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat
    8. Central Noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses
    9. Noradrenergic innervation of the adult rat hippocampal formation
    10. High levels of neuropeptide Y in peripheral Noradrenergic neurons in various mammals including man
    11. Neuropathological and biochemical observations on the Noradrenergic system in Alzheimer’s disease
    12. The locus coeruleus: neurobiology of a central Noradrenergic nucleus
    13. The Noradrenergic system in Alzheimer and multi-infarct dementias.
    14. Establishment of a Noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
    15. Corticotropin-releasing factor activates Noradrenergic neurons of the locus coeruleus
    16. Noradrenergic axon terminals in the cerebral cortex of rat. III. Topometric ultrastructural analysis
    17. The use of dopamine β-hydroxylase as a marker for the central Noradrenergic nervous system in rat brain
    18. Neurobiological mechanisms in human anxiety evidence supporting central Noradrenergic hyperactivity
    19. Noradrenergic innervation of cerebral cortex: widespread effects of local cortical lesions
    20. Noradrenergic modulation of dendrodendritic inhibition in the olfactory bulb
    21. Development of the Noradrenergic innervation of neocortex
    22. Central Noradrenergic neurones concentrate 3 H-oestradiol
    23. Inhibition of both Noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine
    24. Yohimbine induced anxiety and increased Noradrenergic function in humans: effects of diazepam and clonidine
    25. Descending Noradrenergic projections and their spinal terminations
    26. Recent developments in Noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    27. Noradrenergic neurons: morphine inhibition of spontaneous activity
    28. Stimulation of Noradrenergic sympathetic outflow by calcitonin gene-related peptide
    29. Effects of lesions to ascending Noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal Noradrenergic …
    30. Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic Noradrenergic neurons
    31. Intracellular identification of central Noradrenergic and serotonergic neurons by a new double labeling procedure
    32. Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane
    33. Biochemical mapping of Noradrenergic nerves arising from the rat locus coeruleus
    34. The distribution and orientation of Noradrenergic fibers in neocortex of the rat: an immunofluorescence study
    35. Action of various antidepressant treatments reduces reactivity of Noradrenergic cyclic AMP-generating system in limbic forebrain
    36. Serotonergic and Noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones
    37. Noradrenergic modulation of somatosensory cortical neuronal responses to lontophoretically applied putative neurotransmitters
    38. Multiple apparent alpha-Noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine
    39. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha Noradrenergic receptors
    40. Regional topography within Noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase
    41. Possible etiology of schizophrenia: Progressive damage to the Noradrenergic reward system by 6-hydroxydopamine
    42. Noradrenergic innervation of the rat hypothalamus: experimental biochemical and electron microscopic studies
    43. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the Noradrenergic blockers phentolamine or phenoxybenzamine.
    44. Endorphinergic and α-Noradrenergic systems in the paraventricular nucleus: effects on eating behavior
    45. Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm
    46. Distinct α-Noradrenergic receptors differentiated by binding and physiological relationships
    47. Opiates control ACTH through a Noradrenergic mechanism
    48. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study
    49. Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography
    50. The coeruleospinal Noradrenergic neurons: anatomical and electrophysiological studies in the rat
    51. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.
    52. Presynaptic receptor systems on the Noradrenergic neurones of rat brain
    53. Separate involvement of the spinal Noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests
    54. A new major projection from locus coeruleus: the main source of Noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord
    55. Central Noradrenergic control of blood pressure
    56. Synthesis, storage and release of acetylcholine by a Noradrenergic pheochromocytoma cell line
    57. Control of meal size by central Noradrenergic action
    58. Initial development of the Noradrenergic phenotype in autonomic neuroblasts of the rat embryo in vivo
    59. Ultrastructural localization of tyrosine hydroxylase in Noradrenergic neurons of brain
    60. Regional responses of rat brain Noradrenergic neurones to acute intense stress
    61. Tricyclic antidepressants: therapeutic properties and affinity for alpha-Noradrenergic receptor binding sites in the brain
    62. Noradrenergic responses in rat hippocampus: evidence for mediation by α and β receptors in the in vitro slice
    63. Low doses of ethanol disrupt sensory responses of brain Noradrenergic neurones
    64. Single cell activity in the Noradrenergic A-5 region: responses to drugs and peripheral manipulations of blood pressure
    65. Effects of ethanol on central and peripheral Noradrenergic neurons
    66. Noradrenergic involvement in the acute effects of ethanol.
    67. Laminar, tangential and regional organization of the Noradrenergic innervation of monkey cortex: dopamine-β-hydroxylase immunohistochemistry
    68. Activation of a central Noradrenergic projection to cerebellum
    69. Some electrophysiological and pharmacological properties of the cortical, Noradrenergic projection of the locus coeruleus in the rat
    70. Effects of chronic desipramine treatment on rat brain Noradrenergic responses to α-adrenergic drugs
    71. Tricyclic antidepressants: effects on the firing rate of brain Noradrenergic neurons
    72. Biochemical mapping of the Noradrenergic ventral bundle projection sites: evidence for a Noradrenergic-dopaminergic interaction
    73. Central inhibitory Noradrenergic cardiovascular control
    74. Role of Noradrenergic and dopaminergic processes in amphetamine self-administration
    75. Origin and distribution of Noradrenergic innervation in the habenula: a neurochemical study
    76. DSP-4: a novel compound with neurotoxic effects on Noradrenergic neurons of adult and developing rats
    77. Noradrenergic mediation of experimental cerebrovascular spasm
    78. A serotonergic innervation of Noradrenergic neurons in nucleus locus coeruleus: demonstration by immunocytochemical localization of the transmitter specific …
    79. The effects of lesions to ascending Noradrenergic neurons on discrimination learning and performance in the rat
    80. The neuropsychology and neuropharmacology of the dorsal ascending Noradrenergic bundle—a review
    81. Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and Noradrenergic agonists at the spinal level.
    82. Alpha-Noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states
    83. Presynaptic receptor systems on the Noradrenergic neurones of the rabbit pulmonary artery
    84. Functional evidence for subsensitivity of Noradrenergic α2 receptors after chronic desipramine treatment
    85. Abrupt discontinuation of tricyclic antidepressant drugs: evidence for Noradrenergic hyperactivity
    86. Reward, attention and the dorsal Noradrenergic bundle
    87. Immunofluorescence of dopamine-β-hydroxylase application of improved methodology to the localization of the peripheral and central Noradrenergic nervous …
    88. On the role of the central Noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat
    89. Hypothalamic hyperphagia: dissociation from hyperphagia following destruction of Noradrenergic neurons
    90. The dorsal tegmental Noradrenergic projection: An analysis of its role in maze learning.
    91. Nerve growth factor: stimulation of regenerative growth of central Noradrenergic neurons
    92. Dopaminergic and Noradrenergic substrates of positive reinforcement: differential effects of d-and l-amphetamine
    93. Destruction of Noradrenergic neurons in rabbit brainstem elevates plasma vasopressin, causing hypertension
    94. Evidence of a-Noradrenergic reward receptors and serotonergic punishment receptors in the rat brain.
    95. Growth hormone response to clonidine as a probe of Noradrenergic receptor responsiveness in affective disorder patients and controls
    96. Evidence for Noradrenergic mediation of opioid effects on luteinizing hormone secretion
    97. Oxaprotiline: induction of central Noradrenergic subsensitivity by its (+)-enantiomer
    98. Noradrenergic and dopaminergic interactions in escape behavior: Analysis of uncontrollable stress effects
    99. Modulation of rat brain α-and β-adrenergic receptor populations by lesions of the dorsal Noradrenergic bundle
    100. Hippocampal Noradrenergic responses in vivo and in vitro
    101. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, α-Noradrenergic and naloxone receptors
    102. Selective loss of Noradrenergic phenotypic characters in neuroblasts of the rat embryo
    103. Memory enhancement in Korsakoff’s psychosis by clonidine: further evidence for a Noradrenergic deficit
    104. Monoamine-synthesizing enzymes in central dopaminergic, Noradrenergic and serotonergic neurons. Immunocytochemical localization by light and electron …
    105. Inhibitory cardiovascular function of neurons in the caudal ventrolateral medulla of the rabbit: relationship to the area containing A1 Noradrenergic cells
    106. Noradrenergic transmission in depression: under-or overfunction?
    107. Noradrenergic challenges in the affective disorders.
    108. The Noradrenergic system of the amygdala and aversive information processing.
    109. Amygdalar Noradrenergic and dopaminergic mechanisms in the regulation of hunger and thirst-motivated behavior
    110. Noradrenergic rather than serotonergic basis of reward in the dorsal tegmentum.
    111. Central Noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors.
    112. The time course of Noradrenergic pre-and postsynaptic activity during chronic desipramine treatment
    113. Reinnervation of the partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and Noradrenergic afferents
    114. Origins of spinal Noradrenergic pathways demonstrated by retrograde transport of antibody to dopamine-β-hydroxylase
    115. Noradrenergic terminal excitability: Effects of opioids
    116. Noradrenergic sympathetic innervation of lymphoid tissue in the rabbit appendix: Further evidence for a link between the nervous and immune systems
    117. Self-stimulation of Noradrenergic cell group (A6) in locus coeruleus of rats.
    118. Effects of streptozotocin diabetes on the Noradrenergic innervation of the rat heart: a longitudinal histofluorescence and neurochemical study
    119. Methylxanthine activation of Noradrenergic unit activity and reversal by clonidine
    120. Differentiation of dopaminergic and Noradrenergic neurons in rat spinal cord
    121. Activation of lateral geniculate neurons by locus coeruleus or dorsal Noradrenergic bundle stimulation: Selective blockade by the alpha1-adrenoceptor antagonist …
    122. Noradrenergic modulation of glutamate release in the cerebellum
    123. Binding of 3H-catecholamines to α-Noradrenergic receptor sites in calf brain
    124. Alteration of central alpha2-and beta-adrenergic receptors in the rat after DSP-4, a selective Noradrenergic neurotoxin
    125. The effects of vasopressin on memory processes: the role of Noradrenergic neurotransmission
    126. Central Noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit
    127. Catecholamines in the median eminence: new evidence for a major Noradrenergic input
    128. Anticonvulsant and Proconvulsant Actions of Alpha‐and Beta‐Noradrenergic Agonists onEpileptiform Activity in Rat Hippocampus In Vitro
    129. Age-related decline in the activity of Noradrenergic neurons of the rat locus coeruleus
    130. The role of the Noradrenergic system on the formation of synapses in the visual cortex of the rat
    131. Subtotal destruction of central Noradrenergic projections increases the firing rate of locus coeruleus cells
    132. Fluorescence histochemical studies on the Noradrenergic innervation of the canine larynx
    133. Effects of sustained seizures produced by intrahippocampal injection of kainic acid on Noradrenergic neurons: evidence for local control of norepinephrine …
    134. Intracranial self-stimulation in relation to the ascending Noradrenergic fiber systems of the pontine tegmentum and caudal midbrain: A moveable electrode mapping …
    135. Adaptation to stress and brain Noradrenergic receptors
    136. Evidence for ascending Noradrenergic mediation of hypothalamic hyperphagia
    137. Effects of zimelidine on serotoninergic and Noradrenergic neurons after repeated administration in the rat
    138. Noradrenergic and serotonergic mediation of spinal analgesia mechanisms
    139. Alpha-receptor-mediated modulation of transmitter release from central Noradrenergic neurones
    140. Pre-and postsynaptic effects of yohimbine stereoisomers on Noradrenergic transmission in the pulmonary artery of the rabbit
    141. Ultrastructural demonstration of Noradrenergic synapses in the rat central nervous system by dopamine-beta-hydroxylase immunocytochemistry.
    142. Thyroid state: effects on pre-and postsynaptic central Noradrenergic mechanisms
    143. Evidence that self-stimulation of the region of the locus coeruleus in rats does not depend upon Noradrenergic projections to telencephalon
    144. Presnyaptic Noradrenergic regulation during depression and antidepressant drug treatment
    145. Noradrenergic innervation patterns in three regions of medial cortex: an immunofluorescence characterization
    146. Thermoregulatory Noradrenergic and serotonergic pathways to hypothalamic units
    147. Pulmonary Noradrenergic innervation of rat and monkey: a comparative study
    148. Feeding: satiety signal from intestine triggers brain’s Noradrenergic mechanism
    149. Noradrenergic role in the self-administration of ethanol
    150. Participation of central Noradrenergic neurons in arterial baroreceptor reflexes in the rabbit
    151. Two Noradrenergic systems in the brain and their interactions with other monoaminergic neurons.
    152. Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective Noradrenergic neurotoxin
    153. Biochemical mapping of the Noradrenergic projection from the locus coeruleus: A model for studies of brain neuronal pathways
    154. The role of central Noradrenergic neurons in the control of thyrotropin secretion in the rat
    155. Chronic desipramine treatment increases activity of Noradrenergic postsynaptic cells
    156. Exocytosis from large and small dense cored vesicles in Noradrenergic nerve terminals
    157. Noradrenergic inhibitory innervation of canine airways
    158. Are opioid peptides co-transmitters in Noradrenergic vesicles of sympathetic nerves?
    159. The actions of xylamine on central Noradrenergic neurons.
    160. Conditions required for the inhibitory feedback loop in Noradrenergic transmission
    161. The relative importance of dopaminergic and Noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs
    162. Participation of central Noradrenergic neurons in arterial baroreceptor reflexes in the rabbit: a study with intracisternally administered 6-hydroxydopamine
    163. Central Noradrenergic regulation of brain microcirculation
    164. Noradrenergic function and depression, too much or too little?
    165. Noradrenergic influences on sound-induced seizures.
    166. Noradrenergic role in the self-administration of morphine or amphetamine
    167. The locus coeruleus Noradrenergic system—evidence against a role in attention, habituation, anxiety and motor activity
    168. Biochemical evidences for interaction phenomena between Noradrenergic and serotoninergic systems in the cat brain
    169. Noradrenergic influences on catalepsy
    170. Central Noradrenergic inhibition of gastric mucosal blood flow and acid secretion in rats
    171. Dihydroxytryptamines: Effects on Noradrenergic function in mouse heart in vivo
    172. Facilitation of memory consolidation by vasopressin: Mediation by terminals of the dorsal Noradrenergic bundle?
    173. Memory impairment in Korsakoff’s psychosis: a correlation with brain Noradrenergic activity
    174. Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central Noradrenergic neurons
    175. Dorsal Noradrenergic bundle and selective attention in the rat.
    176. The effect of trauma on the activity of central Noradrenergic neurones
    177. Guanyl nucleotide influences on 3H-ligand binding to alpha-Noradrenergic receptors in calf brain membranes.
    178. The activation of tyrosine hydroxylase in Noradrenergic neurons during acute nerve stimulation
    179. Absence of glucoprivic feeding after stress suggests impairment of Noradrenergic neuron function
    180. Brain Noradrenergic neuronal activity affects 3, 4-dihydroxyphenylethyleneglycol (DHPG) levels
    181. Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta …
    182. The role of ventral bundle Noradrenergic neurones in sensory components of sexual behaviour and coitus-induced pseudopregnancy
    183. The involvement of the Noradrenergic system arising from the locus coeruleus in the postnatal development of the cortex in rat brain
    184. Characterization of Noradrenergic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system
    185. Post-mortem measurement of enzymes in human brain: evidence of a central Noradrenergic deficit in schizophrenia
    186. (+/-)-[3H] Epinephrine and (-)[3H] dihydroalprenolol binding to beta1-and beta2-Noradrenergic receptors in brain, heart, and lung membranes.
    187. The central Noradrenergic transmission and the locus coeruleus: a review of the data, and their implications for neurotransmission and neuromodulation
    188. Are the dorsal Noradrenergic bundle projections from the locus coeruleus important for neocortical or hippocampal activation?
    189. Cholecystokinin acts on the hypothalamic “Noradrenergic system” involved in feeding
    190. The role of the septo-hippocampal system and its Noradrenergic afferents in behavioural responses to nonreward
    191. Brain Noradrenergic systems as a prerequisite for developing tolerance to barbiturates
    192. Modulation of Noradrenergic transmission in the guinea‐pig mesenteric artery: an electrophysiological study.
    193. D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and Noradrenergic neurons.
    194. Methylazoxymethanol treatment of fetal rats results in abnormally dense Noradrenergic innervation of neocortex
    195. The immunohistochemical demonstration of Noradrenergic neurons in the rat brain: the use of homologous antiserum to dopamine-β-hydroxylase
    196. Noradrenergic transmission and female sexual behavior of guinea pigs
    197. Self-stimulation in the mesencephalic trajectory of the ventral Noradrenergic bundle
    198. Pharmacological evidence for a functional role of the prejunctional alpha-adrenoreceptor in Noradrenergic neurotransmission in the conscious rat
    199. The Noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic Noradrenergic …
    200. Adaptive changes in central and peripheral Noradrenergic neurons in rats following chronic exercise
    201. Suppression of basal and stimulated Noradrenergic activities by the dopamine agonist bromocriptine in man
    202. Noradrenergic axon terminals in the cerebral cortex of rat. I. Radioautographic visualization after topical application of dl-[3H] norepinephrine
    203. The innervation of cerebral blood vessels by central Noradrenergic neurons
    204. Evidence for interactions between central Noradrenergic neurons and adrenal hormones in learning and memory
    205. Ontogeny of neurochemical markers for Noradrenergic, GABAergic and cholinergic neurons in neocortex lesioned with methylazoxymethanol acetate
    206. Preferential Noradrenergic innervation of alpha-adrenergic receptors in vascular smooth muscle.
    207. Subcellular fractionation of splenic nerve: ATP, chromogranin A and dopamine β-hydroxylase in Noradrenergic vesicles
    208. Dorsal Noradrenergic bundle lesions fail to disrupt self-stimulation from the region of locus coeruleus
    209. Central Noradrenergic function in man: vanillylmandelic acid in CSF
    210. Dopamine and norepinephrine in Noradrenergic axons: a study in vivo of their precursor product relationship by mass fragmentography and radiochemistry
    211. The effects of lesions of lateral tegmental Noradrenergic neurons on components of sexual behaviour and pseudopregnancy in female rats
    212. Noradrenergic axon terminals in the cerebral cortex of rat. II. Quantitative data revealed by light and electron microscope radioautography of the frontal cortex
    213. Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus Noradrenergic neuronal activity
    214. The central Noradrenergic system in the rat: metabolic mapping with α-adrenergic blocking agents
    215. Genetically determined differences in Noradrenergic input to the brain cortex: a histochemical and biochemical study in two inbred strains of mice
    216. Preliminary trial of the Noradrenergic agonist clonidine in psychiatric patients.
    217. Noradrenergic transmission (reply)
    218. Phencyclidine and ketamine: comparison with the effect of cocaine on the Noradrenergic neurones of the rat brain cortex
    219. Alpha-receptor mediated inhibition of A2 Noradrenergic neurons.
    220. Pain and the bulbospinal Noradrenergic system: pain-induced increase in normetanephrine content in the spinal cord and its modification by morphine
    221. Histochemical and pharmacological analysis of Noradrenergic projections to the paraventricular hypothalamus in relation to feeding stimulation
    222. The dorsal Noradrenergic bundle, extinction and non-reward
    223. Pharmacological properties of [3H] dihydroergokryptine binding sites associated with alpha Noradrenergic receptors in rat brain membranes
    224. Noradrenergic synapses for the suppression of feeding behavior.
    225. High‐affinity binding of [3H] desipramine to rat brain: a presynaptic marker for Noradrenergic uptake sites
    226. Modulation in the sensitivity of Noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system
    227. Morphine analgesia and the bulbospinal Noradrenergic system: increase in the concentration of normetanephrine in the spinal cord of the rat caused by analgesics
    228. Ultrastructural identification of Noradrenergic axons and their distribution within the enteric plexuses of the guinea-pig small intestine
    229. Effect of nicotine on single cell activity in the Noradrenergic nucleus locus coeruleus.
    230. Activation of an inhibitory Noradrenergic pathway projecting from the locus coeruleus to the cingulate cortex of the rat
    231. Dynamic changes in brain dopamine-β-hydroxylase activity during anterograde and retrograde reactions to injury of central Noradrenergic axons
    232. The turnover rate of Noradrenergic vesicles.
    233. Noradrenergic sensitivity of the cerebral cortex after chronic ethanol ingestion and withdrawal.
    234. Body weight changes after neurochemical manipulations of lateral amygdala: Noradrenergic and dopaminergic mechanisms
    235. Neurophysiological consequences of presynaptic receptor activation: changes in Noradrenergic terminal excitability
    236. Significance of central Noradrenergic system on harmaline induced tremor
    237. Inhibitory action of the ventral Noradrenergic bundle on the lateral hypothalamic neurons through alpha-Noradrenergic mechanisms in the rat
    238. Chronic treatment with antidepressants: potentiation of clonidine-induced aggression in mice via Noradrenergic mechanism
    239. Post-learning paradoxical sleep, reticular activation and Noradrenergic activity
    240. Selective action of 6-hydroxydopa on Noradrenergic terminals: mapping of preterminal axons of the brain
    241. Noradrenergic mechanisms in the brain and peripheral organs of normotensive and spontaneously hypertensive rats at various ages.
    242. Modification of Noradrenergic hypothalamic system in rat injected with phosphatidylserine liposomes
    243. Noradrenergic regulation of growth hormone secretion in the baboon
    244. Noradrenergic mechanisms in brain and peripheral organs after aortic nerve transection
    245. Development of α‐Noradrenergic and dopaminergic receptor systems depends on maturation of their presynaptic nerve terminals in the rat brain
    246. Assessing the Noradrenergic system in normal aging: a review of methodology
    247. Specific Noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats
    248. Noradrenergic stimulation of cyclic adenosine monophosphate in rat Purkinje neurons: an immunocytochemical study
    249. Temporal sequence of changes in central Noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter …
    250. Noradrenergic processes involved in the locomotor effects of ethanol
    251. Separate Noradrenergic receptors could mediate clonidine-induced antinociception.
    252. Effects of localized intracerebral injections of nerve growth factor on the regenerative growth of lesioned central Noradrenergic neurones
    253. Noradrenergic and non-Noradrenergic nerves containing small granular vesicles in Auerbach’s plexus of the guinea-pig: evidence against the presence of …
    254. ADAPTIVE MECHANISMS OF THE Noradrenergic CYCLIC AMP GENERATING SYSTEM IN THE LIMBIC FOREBRAIN OF THE RAT: ADAPTATION TO …
    255. Noradrenergic axon terminals in the substantia gelatinosa of the rat spinal cord
    256. Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of Noradrenergic fibers innervating the ventral …
    257. Prejunctional effects of 5-hydroxytryptamine on Noradrenergic nerves in the cardiovascular system.
    258. Possible involvement of a central Noradrenergic system in automutilation induced by clonidine in mice
    259. Selective labeling of α-Noradrenergic receptors in rat brain with [3H] dihydroergokryptine
    260. Neurochemical regulation of feeding in the rat: Facilitation by a-Noradrenergic, but not dopaminergic, receptor stimulants.
    261. Structure-activity relations for presynaptic inhibition of Noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors.
    262. Activation of tyrosine hydroxylase from central Noradrenergic neurons by calcium
    263. Korsakoff’s psychosis: Noradrenergic systems and cognitive impairment
    264. Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre-and postsynaptic central Noradrenergic receptor selectivity of α …
    265. Amphetamine-induced inhibition of central Noradrenergic neurons: a pharmacological analysis
    266. Regeneration of normal terminal innervation patterns by central Noradrenergic neurons after 5, 7-dihydroxytryptamine-induced axotomy in the adult rat
    267. Acathisia-syndrome: involvement of Noradrenergic mechanisms
    268. Further studies on the role of Noradrenergic mechanisms in ethanol withdrawal syndrome in rats.
    269. Sympathetic Noradrenergic sprouting in response to central cholinergic denervation: a histochemical study of neuronal sprouting in the rat hippocampal formation
    270. Evidence against a role of the rat’s dorsal Noradrenergic bundle in selective attention and place memory
    271. Presynaptic inhibition by dopamine receptor agonists of Noradrenergic neurotransmission in the rabbit hypothalamus.
    272. Noradrenergic neuromuscular transmission with special reference to arterial smooth muscle
    273. Ontogeny of the Noradrenergic innervation of the rat hippocampal formation
    274. Alpha Noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding
    275. Supraoptic nucleus of the Brattleboro rat has an altered afferent Noradrenergic input
    276. The activities of Noradrenergic and dopaminergic neuron systems in experimental hydrocephalus
    277. Tyrosine hydroxylase: allosteric activation induced by stimulation of central Noradrenergic neurons
    278. Decrease in Noradrenergic activity in hypothalamic nuclei during the development of spontaneous hypertension
    279. Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending Noradrenergic bundles
    280. Ethanol withdrawal in the rat: Involvement of Noradrenergic neurons
    281. Evidence for a selective brain Noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat
    282. Cerebral compensation for chronic Noradrenergic denervation induced by locus ceruleus lesion: recovery of receptor binding, isoproterenol-induced adenylate …
    283. Supersensitivity in rat cerebral cortex: pre-and postsynaptic effects of 6-hydroxydopamine at Noradrenergic synapses
    284. Clonidine: Attenuation of sedative action by facilitated central Noradrenergic neurotransmission
    285. Contribution of Noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and alpha-methyldopa in rabbits.
    286. Individually reared rats: Alteration in Noradrenergic brain functions
    287. Alterations of the cortical Noradrenergic system in chronic cobalt epileptogenic foci in the rat: a histofluorescent and biochemical study
    288. Locus ceruleus region: effects on behavior of cholinergic, Noradrenergic, and opiate drugs injected intracerebrally into freely moving cats
    289. 6-OHDA lesion of the dorsal Noradrenergic bundle alters extinction of passive avoidance.
    290. Changes in Noradrenergic transmission alter the concentration of cytoplasmic progestin receptors in hypothalamus
    291. Role of brainstem and spinal Noradrenergic and adrenergic neurons in the development and maintenance of hypertension in spontaneously hypertensive rats
    292. Clonidine withdrawal: activation of brain Noradrenergic neurons with specifically reduced α2-receptor sensitivity
    293. Cerebral blood flow and oxygen consumption in the rat brain after lesions of the Noradrenergic locus coeruleus system
    294. Noradrenergic overactivity in chronic schizophrenia: evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations
    295. Inhibition of the regenerative growth of central Noradrenergic neurons by intracerebrally administered anti-NGF serum
    296. Possible involvement of a Noradrenergic area of the amygdala with stereotyped behaviour
    297. Dopaminergic but not Noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup
    298. Hypoalgesia induced by blockade of Noradrenergic projections to the raphe magnus: reversal by blockade of Noradrenergic projections to the spinal cord
    299. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat
    300. Noradrenergic pathways and sleep-waking states in cats
    301. Hypoalgesia following microinjection of Noradrenergic antagonists in the nucleus raphe magnus
    302. Presynaptic Noradrenergic α-receptros and modulation of 3H-noradrenaline release from rat brain synaptosomes
    303. Noradrenergic mediation of traumatic spinal cord autodestruction
    304. Microiontophoretic studies on Noradrenergic inhibition from locus coeruleus of spinal trigeminal nucleus neurons.
    305. Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries
    306. Effect of lesions in the ventral Noradrenergic tract produced by microinjection of 6-hydroxydopamine on gonadotropin release in the rat
    307. Chronic treatment with imipramine: Further functional evidence for the enhanced Noradrenergic transmission in flexor reflex activity
    308. Substance P and somatostatin regulate sympathetic Noradrenergic function
    309. Electrophysiologic interactions of antipsychotic drugs with central Noradrenergic pathways
    310. Pharmacological evidence for stimulation of growth hormone secretion by a central Noradrenergic system in dogs
    311. Electrophysiological evidence for presynaptic actions of phencyclidine on Noradrenergic transmission in rat cerebellum.
    312. Axonal transport of noradrenaline and Noradrenergic transmission in rats with streptozotocin-induced diabetes
    313. … from the lower brain stem to the rat cerebellum by the horseradish peroxidase method combined with MAO staining, with special reference to Noradrenergic neurons.
    314. Noradrenergic innervation of the villi of rat jejunum
    315. Estimation of the contribution of peripheral and central Noradrenergic neurones to urinary 3-methoxy-4-hydroxyphenylglycol in the rat
    316. Central Noradrenergic neurons: differential effects on body weight of electrolytic and 6-hydroxydopamine lesions in rats.
    317. Effects of pimozide on Noradrenergic transmission in rabbit isolated ear arteries
    318. Role of neuronal signal input in the down‐regulation of central Noradrenergic receptor function by antidepressant drugs
    319. Local regulation of compensatory Noradrenergic hyperactivity in the partially denervated hippocampus
    320. Effects of Noradrenergic and serotonergic neurons on blood pressure, heart rate and baroreceptor-heart rate reflex of the conscious rabbit
    321. Mechanism of the Noradrenergic motor control on the lower oesophageal sphincter in the cat.
    322. Interactions of Divalent Cations and Guanine Nucleotides at α2‐Noradrenergic Receptor Binding Sites in Bovine Brain Mechanisms
    323. Central cholinergic and Noradrenergic stimulation in spontaneously hypertensive rats.
    324. Immune lesions of Noradrenergic neurones in rat central nervous system produced by antibodies to dopamine-β-hydroxylase
    325. Visualization of central Noradrenergic neurons in thick sections by the unlabeled antibody method: a transmitter-specific Golgi image
    326. Effects of amphetamine and its hydroxylated metabolites on central Noradrenergic mechanisms
    327. Changes in Noradrenergic neurotransmission in rat cerebellum during aging
    328. Multiple α2‐Noradrenergic Receptor Sites in Rat Brain: Selective Regulation of High‐Affinity [3H] Clonidine Binding by Guanine Nucleotides and Divalent Cations
    329. Effects of estrogen on the excitability of neurons projecting from the Noradrenergic A1 region to the preoptic and anterior hypothalamic area
    330. Circling behavior following systemic d-amphetamine administration: potential Noradrenergic and dopaminergic involvement
    331. Sympathetic Noradrenergic sprouting in response to central cholinergic denervation
    332. Localization of Noradrenergic terminals in sympathetic preganglionic nuclei of the rat: demonstration by immunocytochemical localization of dopamine-β-hydroxylase
    333. Alterations in turnover and endogenous levels of norepinephrine in cerebral cortex following electrical stimulation and acute axotomy of cerebral Noradrenergic …
    334. Evidence for hypothalamic Noradrenergic involvement in naloxone-induced stimulation of luteinizing hormone release
    335. A fluorescent histochemical study of changes in Noradrenergic neurons following experimental cerebral infarction in the rat
    336. Effects of clozapine on the activity of central dopaminergic and Noradrenergic neurons
    337. Interaction between Noradrenergic and cholinergic systems in the rat brain: behavioural function in locomotor activity
    338. Participation of adrenergic and Noradrenergic neurones in central connections of arterial baroreceptor reflexes in the rat.
    339. Changes in body weight and food-related behaviour induced by destruction of the ventral or dorsal Noradrenergic bundle in the rat
    340. Evidence for Noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats
    341. Development of cortical and nigro-neostriatal dopaminergic systems after destruction of central Noradrenergic neurones in foetal or neonatal rats
    342. Acquisition and extinction of continuously and partially reinforced running in rats with lesions of the dorsal Noradrenergic bundle
    343. Discontinuation of chronic clonidine treatment: evidence for facilitated brain Noradrenergic neurotransmission
    344. Enhanced sensitivity to Noradrenergic agonists and tolerance development to α-methyltyrosine in the rat
    345. Functional activity of the Noradrenergic innervation of large cerebral arteries
    346. The relative role of recapture and of de novo synthesis for the maintenance of neurotransmitter homeostasis in Noradrenergic nerves
    347. Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities
    348. A correlation between the effects of anti‐mitotic drugs on microtubule assembly in vitro and the inhibition of axonal transport in Noradrenergic neurones.
    349. Lack of effect of Noradrenergic denervation of the hypothalamus and medial preoptic area on the feedback regulation of gonadotropin secretion and the estrous cycle …
    350. The effect of bilateral lesions of the ventral Noradrenergic bundle on endocrine-induced changes of tyrosine hydroxylase in the rat median eminence
    351. Neurotransmitters and receptor binding in amygdaloid kindled rats: serotonergic and Noradrenergic modulatory effects
    352. Sympathetic Noradrenergic innervation of guinea-pig liver: histofluorescence and pharmacological studies.
    353. Noradrenergic mediation of the positive reinforcing properties of ethanol: II. Extinction of ethanol-drinking behavior in laboratory rats by inhibition of dopamine-beta …
    354. The dorsal Noradrenergic bundle and varieties of passive avoidance
    355. Noradrenergic responses in rat hippocampus: electrophysiological actions of direct-and indirect-acting sympathomimetics in the in vitro slice.
    356. The distribution of Noradrenergic nerves and small, intensely fluorescent (SIF) cells in the cat urinary bladder
    357. Noradrenergic reward mechanisms, recovery of function, and schizophrenia
    358. A new approach to the role of noradrenaline in learning: problem-solving in the marmoset after α-Noradrenergic receptor blockade
    359. Amphetamine and Noradrenergic reward pathways
    360. Effects of thyroid hormone deficiency on pre-and postsynaptic Noradrenergic mechanisms in the rat cerebral cortex.
    361. Tyrosine hydroxylase: delayed activation in central Noradrenergic neurons and induction in adrenal medulla elicited by stimulation of central cholinergic receptors.
    362. Tyrosine hydroxylase activity in Noradrenergic neurons of the locus coeruleus after reserpine administration: sequential increase in cell bodies and nerve terminals
    363. Failure of the hypothalamic Noradrenergic system to function in adult androgen-sterilized rats
    364. Biochemical observations on the formation of small Noradrenergic vesicles in the splenic nerve of the dog
    365. LONG‐TERM EFFECTS OF N‐2‐CHLOROETHYL‐N‐ETHYL‐2‐BROMOBENZYLAMINE HYDROCHLORIDE ON Noradrenergic NEURONES IN THE RAT …
    366. Nonlinear changes in activity and emotional reactivity scores following central Noradrenergic lesions in rats
    367. Fetally-induced Noradrenergic hyperinnervation of cerebral cortex results in persistent down-regulation of beta-receptors
    368. Sprouting of Noradrenergic fibers in hippocampus after medial septal lesions: contributions of the central and peripheral nervous systems
    369. Substantia nigra self-stimulation: dependence on Noradrenergic reward pathways
    370. Biochemical identification of multiple GABAB binding sites: association with Noradrenergic terminals in rat forebrain
    371. Noradrenergic neurotransmission in the brain of a convulsive mutant mouse
    372. Brainstem Noradrenergic system depression by cyclobenzaprine
    373. The dopaminergic and Noradrenergic blockades: a new treatment for headache
    374. Identification of and interactions between Noradrenergic and serotonergic neurites in the myenteric plexus
    375. Rotational behaviour produced in rats by unilateral electrolytic lesions of the ascending Noradrenergic bundles
    376. Maturation of sympathetic neurotransmission in the rat heart. VIII. Slowed development of Noradrenergic synapses resulting from hypothyroidism.
    377. Noradrenergic function during stress and depression: An alternative view
    378. Inhibition of the release of LH and ovulation by activation of the Noradrenergic system. Effect of interrupting the ascending pathways
    379. Functional evidence for postsynaptic supersensitivity of central Noradrenergic receptors after denervation
    380. Changes in Noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT
    381. Modulation of Noradrenergic transmission in the rabbit ear artery by dopamine
    382. Effect of ECT on dopaminergic and Noradrenergic mechanisms
    383. The activating action of vincamine, piracetam, and hydergine on the activity of the Noradrenergic neurons of the locus coeruleus
    384. Noradrenergic stimulation in vivo increases (Na+, K+)-adenosine triphosphatase activity
    385. Corticosteroid involvement in the changes in Noradrenergic responsiveness of tissues from rats made hypertensive by short-term isolation
    386. Stereoselectivity of catecholamine uptake in Noradrenergic and dopaminergic peripheral organs
    387. The action of adenosine on Noradrenergic neuronal inhibition induced by stimulation of locus coeruleus
    388. Some aspects of the reaction of central and peripheral Noradrenergic neurons to injury
    389. Kainic acid spares fibers of the dorsal Noradrenergic bundle
    390. Hypothyroidism elicits electrophysiological Noradrenergic subsensitivity in rat cerebellum
    391. Phenothiazine antagonism of the Noradrenergic inhibition of cerebellar Purkinje neurons
    392. Food intake and body weight: effects of specific and non-specific lesions in the midbrain path of the ascending Noradrenergic neurons of the rat
    393. Tetrodotoxin-sensitive and-resistant effects of veratridine on the Noradrenergic neurone of the rat vas deferens
    394. Central Noradrenergic activity and the formation of glycol sulfate metabolites of brain norepinephrine
    395. Opiate-enhanced toxicity and Noradrenergic sprouting in rats treated with 6-hydroxydopa
    396. Effects of drugs affecting the Noradrenergic system on convulsions in the quaking mouse
    397. Specific uptake and retrograde flow of antibody to dopamine-β-hydroxylase by central nervous system Noradrenergic neurons in vivo
    398. Location of Noradrenergic structures in the central artery of the rabbit ear
    399. Peripheral and intrahypothalamic cholecystokinin act on the Noradrenergic “feeding circuit” in the rat’s diencephalon
    400. Pilocarpine: Noradrenergic mechanism of a cholinergic drug
    401. Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.
    402. Gel electrophoresis of soluble and insoluble proteins of Noradrenergic vesicles from ox splenic nerve: a comparison with proteins of adrenal chromaffin granules
    403. Noradrenergic innervation of the penis in control and streptozotocin‐diabetic rats: Evidence of autonomic neuropathy
    404. Differential supersensitivity of β-receptor subtypes in rat cortex and cerebellum after central Noradrenergic denervation
    405. Two-way avoidance and acute shock stress induced alterations of regional Noradrenergic, dopaminergic and serotonergic activity in Roman high-and low-avoidance …
    406. Schedule dependent changes in operant responding after lesions of the dorsal tegmental Noradrenergic projection
    407. Characteristics of the dopaminergic and Noradrenergic systems of the pancreatic islets
    408. α-Noradrenergic modulation of hypothalamic self-stimulation: Studies employing clonidine, 1-phenylephrine and α-methyl-p-tyrosine
    409. Morphological effects of osmolarity on purified Noradrenergic vesicles
    410. Increased ouabain binding after repeated Noradrenergic stimulation
    411. Development and aging of Noradrenergic cell bodies and axon terminals in the chicken
    412. Genetic variation, chronic stress, and the central and peripheral Noradrenergic systems
    413. Vasopressin maintenance of ethanol tolerance requires intact brain Noradrenergic systems
    414. Influence of lesions of the Noradrenergic locus coeruleus system on the cerebral metabolic response to bicuculline-induced seizures
    415. Prolonged activation of tyrosine hydroxylase in Noradrenergic neurones of rat brain by cholinergic stimulation
    416. Noradrenergic basis of inhibition between reward and punishment in amygdala.
    417. Brain Noradrenergic responses to training and to amnestic frontal cortex stimulation
    418. Noradrenergic innervation of the median eminence. Microspectrofluorimetric and pharmacological study in the duck, Anas platyrhynchos
    419. Hippocampal α-and β-adrenergic receptors: comparison of [3H] dihydroalprenolol and [3H] WB 4101 binding with Noradrenergic innervation in the rat
    420. Evidence for an interaction of opioid and Noradrenergic locus coeruleus systems in the regulation of environmental stimulus-directed behavior
    421. Lanthanum inhibits brain adenylate cyclase and blocks Noradrenergic depression of Purkinje cell discharge independent of calcium
    422. Noradrenergic or dopaminergic activity in chronic schizophrenia
    423. Evidence against Noradrenergic regulation of vasodilation in rat brown adipose tissue
    424. Involvement of alpha Noradrenergic receptors in mediation of brain polyphosphoinositides metabolism in vivo.
    425. Further evidence for the heterogeneous storage of noradrenaline in central Noradrenergic terminals
    426. The effects of interruption of the ventral Noradrenergic pathway on the proestrous discharge of prolactin in the rat
    427. Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central Noradrenergic neurons
    428. Excitatory effects of ACTH on Noradrenergic neurons of the locus coeruleus in the rat
    429. Effects of presynaptic modulators on Ca2+-induced noradrenaline release from central Noradrenergic neurons
    430. Effects of some catecholamines on Noradrenergic transmission in the rabbit ear artery.
    431. … of sympathetic neurotransmission in the rat heart. II. Enhanced development of presynaptic and postsynaptic components of Noradrenergic synapses as a result …
    432. Blockade of intracranial self-stimulation by antipsychotic drugs: Failure to correlate with central alpha-Noradrenergic blockade
    433. Effects of lesions of the Locus coeruleus and the ventral Noradrenergic bundle on the antinociceptive action of clonidine in rats.
    434. Alterations in Noradrenergic function during clorgyline treatment
    435. Intact selective attention in rats with lesions of the dorsal Noradrenergic bundle.
    436. Altered exploratory behaviour after 6-OHDA lesion to the dorsal Noradrenergic bundle
    437. Immune lesions of central Noradrenergic neurons produced by antibodies to dopamine-β-hydroxylase
    438. Recent morphological and functional studies on hypothalamic dopaminergic and Noradrenergic mechanisms
    439. Effects of 6-hydroxydopa on Noradrenergic neurons in developing rat brain.
    440. Localization of the Noradrenergic nervous system in human brain
    441. Urinary excretion of catechol amines in the immunosympathectomized rat—balance phenomena between the adrenergic and the Noradrenergic system
    442. The role of Noradrenergic and serotonergic systems in the hippocampal kindling effect
    443. Effects of chemical lesion of the ventral Noradrenergic bundle or of the medial preoptic area on preovulatory LH release in rats
    444. The inhibitory role of! b-Noradrenergic receptors in oxytocin release during suckling.
    445. Increased hypothalamic Noradrenergic activity in one-kidney, one-clip renovascular hypertensive rats.
    446. Improved isolation of small Noradrenergic vesicles from rat seminal ducts following castration. A density gradient centrifugation and morphological study
    447. Regenerations of the Noradrenergic innervation of the cardiovascular system of the chick following treatment with 6‐hydroxydopamine
    448. Is the Noradrenergic “feeding circuit” in hypothalamus really an olfactory system?
    449. Modulation of dopaminergic transmission by alpha-Noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists
    450. Sprouting of Noradrenergic nerve terminals subsequent to freeze lesions of rabbit cerebral cortex
    451. Light and electron microscopic observations on Noradrenergic nerves and striated muscle cells of the guinea pig urethra
    452. Different alterations in the development of the Noradrenergic innervation of the cerebellum and the brain stem produced by neonatal 6-hydroxydopa
    453. Hypothalamic “coding” in the unanesthetized monkey of Noradrenergic sites mediating feeding and thermoregulation
    454. d-Amphetamine at low doses suppresses Noradrenergic functions
    455. Studies of Noradrenergic influence on cardiac ornithine decarboxylase in rats
    456. Age-related alterations in Noradrenergic neurotransmission in Sprague-Dawley and Fischer 344 rat strains
    457. Behavioral effects of lesions of the central Noradrenergic bundles in the rat
    458. Potential Noradrenergic regulation of serotonergic neurons in the median raphe nucleus
    459. Central Noradrenergic-cholinergic interaction in regulation of gastric acid secretion in rats
    460. Abnormalities of cerebral oxidative metabolism with aging and their relation to the central Noradrenergic system
    461. [3H] Epinephrine and [3H] norepinephrine binding to α-Noradrenergic receptors in calf brain membranes
    462. The development of neocortical Noradrenergic innervation in the mouse: a quantitative radioenzymatic analysis
    463. Noradrenergic agonists and antagonists: effects on avoidance behaviour in rats.
    464. Evaluation of the regenerative capacity of central dopaminergic, Noradrenergic and cholinergic neurones using iris implants as targets
    465. Axonal transport of [3H] fucosyl glycoproteins in Noradrenergic neurons in the rat brain
    466. Alpha-adrenoreceptor mediated inhibition of brain Noradrenergic neurons after acute and chronic treatment with tricyclic antidepressants
    467. Acute or chronic changes of Noradrenergic transmission do not affect the α-adrenoceptor-mediated inhibition of 3H-serotonin release in the cerebral cortex
    468. The effect of amitriptyline on presynaptic mechanisms in Noradrenergic nerves.
    469. Purkinje cell loss and the Noradrenergic system in the cerebellum of pcd mutant mice
    470. Increased Noradrenergic Metabolism in the Cerebellum of the Mouse Mutant Dystonia Musculorum
    471. Central Noradrenergic-cholinergic interaction and locomotor behavior
    472. Effects of lesions in the ventral Noradrenergic bundle on behavior and response to psychotropic drugs in rats
    473. Receptor involvement in the central Noradrenergic inhibition of ACTH secretion in the rat
    474. Clonidine suppression of Noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
    475. Noradrenergic afferents to median eminence: inhibitory role in rhythmic growth hormone secretion
    476. Recycling of Noradrenergic storage vesicles of isolated rat vas deferens
    477. Effects of Noradrenergic neuronal activity on 3, 4-dihydroxyphenylethylene glycol (DHPG) levels. Quantitation by high performance liquid chromatography
    478. Pharmacological studies on the Noradrenergic control of luteinizing hormone secretion in the domestic fowl
    479. Noradrenergic synapses and effects of noradrenaline on interneurons in the ventral horn of the cat spinal cord
    480. Unilateral blockade of the dorsal ascending Noradrenergic bundle and septal elicitation of hippocampal theta rhythm
    481. Differential effects of typical and atypical neuroleptics on alpha-Noradrenergic and dopaminergic postsynaptic receptors
    482. A study of long-term effects of guanethidine on peripheral Noradrenergic neurones of the rat
    483. Structural and steric requirements for β-phenethylamines as agonists of the Noradrenergic cyclic AMP generating system in the rat limbic forebrain
    484. Changes in Noradrenergic terminal excitability induced by amphetamine and their relation to impulse traffic
    485. Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central Noradrenergic neurons. I. In vivo stimulation of the locus coeruleus.
    486. Noradrenergic subsensitivity of rat liver homogenates during chronic ethanol ingestion.
    487. Presence and axonal transport of cholinoceptor, but not adrenoceptor sites on a cat Noradrenergic neurone
    488. A comparison of rates of depletion and recovery of noradrenaline stores of peripheral and central Noradrenergic neurones after reserpine administration: importance …
    489. Parallel changes in brain flunitrazepam binding and density of Noradrenergic innervation
    490. PRELIMINARY ESTIMATES OF THE DOPAMINE β‐HYDROXYLASE CONTENT AND ACTIVITY IN PURIFIED Noradrenergic VESICLES1
    491. Effects of vinblastine on Noradrenergic axons
    492. Beta-1 adrenergic receptors mediate Noradrenergic facilitation of Purkinje cell responses to gamma-aminobutyric acid in cerebellum of rat
    493. Enhanced neophobia but normal plasma corticosterone levels in rats with dorsal Noradrenergic bundle lesions
    494. Changes in ingestive behavior following interruption of a Noradrenergic projection to the paraventricular nucleus: Histochemical and neurochemical analyses
    495. Brain 3, 4-dihydroxyphenylethyleneglycol levels are dependent on central Noradrenergic neuron activity
    496. Increased brain serotonergic and Noradrenergic activity after repeated systemic administration of the beta-2 adrenoceptor agonist salbutamol, a putative …
    497. Enhancement of sprouting and putative regeneration of central Noradrenergic fibers by morphine
    498. The central Noradrenergic system and affective response to MAO inhibitors
    499. Studies on the mechanism of sprouting of Noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa
    500. Audiogenic seizures in rats: relation to Noradrenergic neurons of the locus coeruleus.
    501. Ultrastructural evidence for remodelling in a central Noradrenergic pathway following electrolytic lesioning
    502. Role for lateral tegmental Noradrenergic neurons in the vasopressin response to hypertonic saline
    503. Electrophysiological and biochemical sequelae of the destruction of hippocampal Noradrenergic afferents by DSP4
    504. Noradrenergic sprouting in response to cholinergic denervation: the sympathohabenular connection
    505. Ultrastructural identification of Noradrenergic nerve terminals and vasopressin-containing neurons of the paraventricular nucleus in the same thin section.
    506. Interaction between Noradrenergic and serotonergic brain systems as evidenced by behavioral and biochemical effects of microinjections of adrenergic agonists and …
    507. Long-term unilateral Noradrenergic denervation: monoamine content and 3H-prazosin binding sites in rat neocortex
    508. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central Noradrenergic and dopaminergic pathways
    509. Central Noradrenergic mechanisms and the cardiovascular effects of intracerebroventricular (+)-and (−)-propranolol in the conscious rabbit
    510. Noradrenergic innervation of the human bladder in neurogenic dysfunction
    511. Serotonergic and Noradrenergic mechanisms involved in the cardiovascular effects of angiotensin II injected into the anterior hypothalamic preoptic region of rats
    512. Brain (Na+, K+)‐ATPase and Noradrenergic Activity: Effects of Hyperinnervation and Denervation on High‐Affinity Ouabain Binding
    513. Noradrenergic subsensitivity and supersensitivity of the cerebral cortex after reserpine treatment.
    514. 6-Hydroxydopamine, Noradrenergic reward, and schizophrenia
    515. Interaction between Noradrenergic and Serotonergic Mechanisms on the Central Regulation of Blood Pressure in the Rat: A Study Using Experimental Central …
    516. Differential responsiveness of central Noradrenergic and dopaminergic neuron tyrosine hydroxylase to hypophysectomy, ACTH, and glucocorticoid …
    517. Axonal transport of [3H] proteins in a Noradrenergic system of the rat brain
    518. Noradrenergic influences on dopamine-dependent behaviour in rats [proceedings].
    519. Noradrenergic feeding system in monkey hypothalamus is altered by localized perfusion of glucose, insulin, 2-DG and eating
    520. Histochemical studies of Noradrenergic innervation of the liver in untreated and daunomycin-pretreated guinea-pigs
    521. Immunocytochemical characterization of the dopaminergic and Noradrenergic innervation of the rat neocortex during early ontogeny
    522. Noradrenergic fiber sprouting in the cerebellum
    523. The development of operant responses by Noradrenergic activation and cholinergic suppression of movements.
    524. Effects of β-adrenoceptor antagonists on the firing rate of Noradrenergic neurones in the locus coeruleus of the rat
    525. Selective Noradrenergic denervation and 3H-prazosin binding sites in rat neocortex
    526. Stimulatory effect of chlordiazepoxide on locomotor activity in mice: importance of Noradrenergic transmission.
    527. A fluorescence histochemical study of the degeneration and regeneration of Noradrenergic nerves in the chick following treatment with 6-hydroxydopamine
    528. Designing a non-neuroleptic antischizophrenic drug: the Noradrenergic strategy
    529. Pharmacological suppression of eating behavior in relation to diencephalic Noradrenergic receptors
    530. … SUBSTANTIA NIGRA OF THE RAT BRAIN: EFFECTS OF γ‐BUTYROLACTONE AND DESTRUCTION OF Noradrenergic AFFERENTS SUGGEST FORMATION …
    531. Enzyme studies in tardive dyskinesia. III. Noradrenergic hyperactivity in a subgroup of dyskinetic patients.
    532. A pre‐junctional action of 5‐hydroxytryptamine and methysergide on Noradrenergic nerves in dog isolated saphenous vein
    533. Noradrenergic mechanisms in hemorrhagic shock of the rat.
    534. Histochemical evidence for the degeneration of peripheral Noradrenergic axons following intravenous injection of antibodies to dopamine-β-hydroxylase
    535. Differential labelling of α and β-Noradrenergic receptors in calf cerebellum membranes with 3 H-adrenaline
    536. Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central Noradrenergic neurons. II. Depolarized hippocampal slices.
    537. Noradrenergic function in affective illness
    538. Relation between functional maturation of cervical sympathetic innervation and ontogeny of α-Noradrenergic smooth muscle contraction in the rat
    539. Noradrenaline content correlated to matrix density in small Noradrenergic vesicles from rat seminal ducts
    540. Effect of mianserin on Noradrenergic transmission in the rat anococcygeus muscle
    541. Facilitation of shock-induced fighting in the rat after DSP-4, a selective Noradrenergic neurotoxin
    542. Stimulation of the dorsal Noradrenergic bundle and field potentials in the locus coeruleus
    543. Clonidine-induced hyperphagia in monkeys: Evidence for α 2-Noradrenergic receptor mediation
    544. The Noradrenergic system in cultured aggregates of fetal rat brain cells: Morphology of the aggregates and pharmacological indices of Noradrenergic neurons
    545. Critical periods for Noradrenergic regeneration in rat brain regions following neonatal subcutaneous 6-hydroxydopamine
    546. Enhancement of learning four weeks after stimulation of the nucleus locus coeruleus in the rat: differential effects of dorsal Noradrenergic bundle lesion and lesion of …
    547. Electrical stimulation of mesencephalic Noradrenergic pathway: effects on luteinizing hormone levels in blood of ovariectomized and ovariectomized, steroid-primed …
    548. The anticonvulsant effect of carbonic anhydrase inhibitors in mice—a Noradrenergic mechanism of action
    549. Effects of Noradrenergic stimulation of the medial and lateral hypothalamus on cardiovascular responses
    550. Evidence that most of the dopamine β-hydroxylase is not membrane bound in purified large dense cored Noradrenergic vesicles
    551. Reactive proliferation of brain stem Noradrenergic nerves following neonatal cerebellectomy in rats: role of target maturation on neuronal response to injury during …
    552. Histochemical studies of sympathetic sprouting: fluorescence morphology of Noradrenergic axons
    553. Biochemical evidence for re-use of Noradrenergic storage vesicles in the guinea-pig heart
    554. Central Noradrenergic adaptation to long-term treatment with imipramine in rhesus monkeys
    555. The role of hypothalamic Noradrenergic neurons in food intake regulation
    556. Lesions of the dorsal Noradrenergic bundle and rewarded running: the role of pretraining
    557. Experimental studies on hatching behavior in the chick. IV. Evidence for the role of a Noradrenergic mechanism
    558. The role of the ventral Noradrenergic bundle in relation to endorphins in the control of core temperature, open-field and ingestive behaviour in the rat
    559. Prejunctional alpha-adrenoreceptors subserve a physiological role in cardiac Noradrenergic transmission.
    560. Strain differences in the facilitatory action of angiotensin on Noradrenergic transmission in the rat mesentery
    561. Selective Noradrenergic denervation of the heart following intravenous injections of vinblastine or vincristine.
    562. Locomotor activity of rats after stimulation of the nucleus locus coeruleus region or after lesion of the dorsal Noradrenergic bundle: Effects of clonidine, prazosin and …
    563. Involvement of central Noradrenergic mechanisms in the rebound hypertension following clonidine withdrawal.
    564. Modification of the Noradrenergic cyclic AMP generating system in the rat limbic forebrain by amphetamine: Role of its hydroxylated metabolites
    565. Tyrosine hydroxylase activation and transmitter release from central Noradrenergic neurons by electrical field stimulation
    566. Norepinephrine levels in developing pigeon brain: effect of monocular deprivation on the Wulst Noradrenergic system
    567. Attenuation of self-stimulation from substantia nigra but not dorsal tegmental Noradrenergic bundle by lesions of sulcal prefrontal cortex
    568. Disinhibition of rat cerebellar Purkinje neurons from Noradrenergic inhibition during rising blood ethanol.
    569. The use of the rat right ventricle strip in studies on Noradrenergic transmission
    570. Role on blood pressure regulation of Noradrenergic neurons originating from the locus coeruleus in the Kyoto-Wistar rat
    571. The effect of selective lesions of brain Noradrenergic systems on the development of barbiturate tolerance in rats
    572. Release of [3H]‐amezinium from cortical Noradrenergic axons: a model for the study of the α‐autoreceptor hypothesis
    573. Noradrenergic action of amphetamine following degeneration of descending monoaminergic fibers in the spinal cord
    574. Effects of lesions of the ventral Noradrenergic bundle on aggressive behavior in rats
    575. Central Noradrenergic neurons: structure-function considerations
    576. Pharmacological and ultrastructural studies on the electron dense cores of the vesicles that accumulate in Noradrenergic axons constrictedin vitro
    577. Sites of Noradrenergic innervation of the jejunal villus.
    578. Comparison of two α-Noradrenergic agonists (clonidine and guanfacine) on norepinephrine turnover in the cortex of rats during morphine abstinence
    579. The coexistence and release of bovine pancreatic polypeptide-like immunoreactivity from Noradrenergic superior cervical ganglia neurons
    580. Are glomus cells in the rat carotid body dopaminergic or Noradrenergic?
    581. Involvement of Noradrenergic and dopaminergic neurons in shock-induced jumping in rats
    582. The effects of destruction on Noradrenergic ascending ventral bundles and tetrabenazine on formation of stress-induced gastric ulcer
    583. EFFECTS OF THE HISTAMINE H2‐RECEPTOR BLOCKING DRUGS BURIMAMIDE AND CIMETIDINE ON Noradrenergic TRANSMISSION IN THE ISOLATED …
    584. Studies on the role of dopaminergic systems in morphine-induced motor activity. Comparison with Noradrenergic and cholinergic systems.
    585. In vivo effects of noradrenaline and Noradrenergic receptor agonists and antagonists on rat cerebellar cyclic GMP levels
    586. Iontophoresis of Li+ antagonizes Noradrenergic synaptic inhibition of rat cerebellar Purkinje cells
    587. Noradrenergic and dopaminergic regulation of GH and prolactin in baboons
    588. The renal nerves in dogs: Noradrenergic and dopaminergic?
    589. Effects of prazosin, phentolamine and yohimbine on Noradrenergic transmission in the rat right ventricle in vitro
    590. Fluorescence histochemical and ultrastructural observations on the effects of intravenous injections of vinblastine on Noradrenergic nerves
    591. Adrenalectomy inhibits Noradrenergic, adrenergic, and vasopressor responses to angiotensin II in the Pekin duck (Anas platyrhynchos)
    592. Induction and delayed activation of tyrosine hydroxylase in Noradrenergic neurons of A1 and A2 groups of medulla oblongata of rat
    593. Regulation of synaptosomal tyrosine hydroxylation in different brain regions with Noradrenergic innervation
    594. Positive reinforcement produced by Noradrenergic stimulation of the hypothalamus in rats
    595. Mechanism of action of piribedil on Noradrenergic neurons in rat brain
    596. The effects of Noradrenergic denervation on muscarinic receptors of smooth muscle.
    597. Cardiovascular Functions of Central Noradrenergic and Serotonergic Neurons in Conscious Rabbits: Their Contributions to the Central Actions of Clonidine
    598. Lesions of the dorsal Noradrenergic projection attenuate morphine-but not amphetamine-induced conditioned taste aversion
    599. Functional properties of Noradrenergic nervous system in rat colonic mucosa: uptake of [3H] norepinephrine
    600. An interaction of histamine H2-receptor antagonists with the Noradrenergic system in rat brain
    601. Differentiation of Noradrenergic and dopaminergic nerves in the rat kidney: evidence against significant dopaminergic innervation
    602. The mode of action of tetrabenazine on peripheral Noradrenergic nerves.
    603. Ca2+-induced noradrenaline release from central Noradrenergic neurons promoted by high K+ concentration or ionophore A23187
    604. Noradrenergic innervation of the arrectores pilorum muscles of the ox (Bos taurus)
    605. Effect of clonidine on the Noradrenergic cyclic AMP generating system in the limbic forebrain and on medial forebrain bundle self-stimulation behavior
    606. The anticonvulsant action of the carbonic anhydrase inhibitor methazolamide: possible involvement of a Noradrenergic mechanism
    607. Neonatal hormone treatment and maturation of the pineal Noradrenergic system: hydrocortisone and thyroxine
    608. Development of and recovery from subsensitivity of the Noradrenergic cyclic AMP generating system in brain
    609. Evidence for involvement of central Noradrenergic neurons in the cardiovascular depression induced by morphine in the rat
    610. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral Noradrenergic neurons
    611. The actions of dopaminergic and Noradrenergic antagonists on conditioned avoidance responses in intact and 6-hydroxydopamine-treated rats
    612. Evidence for an interrelationship between ventral Noradrenergic bundle and CNS endorphins in the control of nociception in the rat
    613. Destruction of Noradrenergic cell bodies by intracerebral 6-hydroxydopamine in the newborn rat
    614. Effect of lesions of the brain Noradrenergic systems on amphetamine-induced hyperthermia and locomotor stimulation.
    615. Labeling knife cuts: A new method for revealing the functional anatomy of the CNS demonstrated on the Noradrenergic dorsal bundle
    616. Central Noradrenergic receptors: localization, function and molecular mechanisms
    617. Depression and enhancement of baroreceptor pressor response in cats after intracerebroventricular injection of Noradrenergic blocking agents: dependence on …
    618. Dual presynaptic effects of 5‐hydroxytryptamine on peripheral Noradrenergic synapses
    619. Hormonally-mediated Noradrenergic modulation of memory processes
    620. Evidence for a Noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, α-dimethyl-m-tyramine (H 77/77) in rats
    621. A new intracellular medium for prolonged viability of Noradrenergic storage vesicles from rat brain
    622. Latency of dopamine β-hydroxylase in purified Noradrenergic vesicles
    623. Altered hindlimb extension in the rat after DSP-4: a useful marker of central Noradrenergic depletion
    624. Dementia and cerebral Noradrenergic innervation.
    625. Noradrenergic control of blood vessels in the premature lamb fetus
    626. Alpha-Noradrenergic receptor binding sites in bovine aorta
    627. Neuropharmacology of 3-isobutylmethylxanthine: effects on central Noradrenergic systems in vivo.
    628. DDT-induced myoclonus: serotonin and alpha Noradrenergic interaction.
    629. Noradrenergic and dopaminergic influences on thirst
    630. Glucocorticoid effects on serotonergic and Noradrenergic facilitation of spinal monosynaptic transmission
    631. Inhibition of Ca 2+-induced noradrenaline release from central Noradrenergic neurons by morphine
    632. Calcium ions, morphine tolerance and Noradrenergic transmission in the mouse vas deferens
    633. Lesions of the ventral Noradrenergic (norepinephrinergic) bundle affect brain and pituitary pools of endorphins and the response of these to stress in rats
    634. Noradrenergic action in the developing rat cerebellum: interaction between norepinephrine and synaptically-evoked responses of immature Purkinje cells
    635. Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on Noradrenergic and dopaminergic innervation of the cerebral cortex
    636. Noradrenergic neurons: post-stimulation increase in catecholamine biosynthesis
    637. Dissociation between central and peripheral Noradrenergic activity in essential hypertension
    638. Electrophysiological and biochemical responses of Noradrenergic neurons to a non-amphetamine CNS stimulant
    639. Developmental localization of Noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment
    640. Responses of the melanophores of the fiddler crab, Uca pugilator, to drugs affecting Noradrenergic neurotransmission: Further evidence for norepinephrine as a …
    641. Selective destruction of the ventral Noradrenergic bundle but not of the locus coeruleus elevates plasma levels of β-endorphin immunoreactivity in rats
    642. The Noradrenergic innervation of cerebellar Purkinje cells: localization, function, synaptogenesis, and axonal sprouting of locus coeruleus
    643. Response: 6-Hydroxydopamine, Noradrenergic Reward, and Schizophrenia
    644. Noradrenergic sympathetic blockade: Lack of effect on memory or retrograde amnesia
    645. Noradrenergic and cholinergic action on neuronal activity during self-stimulation behavior in the rat
    646. Changes in tyrosine hydroxylase and dopamine-β-hydroxylase activities during degeneration of Noradrenergic axons produced by antibodies to dopamine-β …
    647. 6-OHDA lesion to the dorsal Noradrenergic bundle alters morphine-induced locomotor activity and catalepsy
    648. The regulation of the Noradrenergic neuron
    649. Role of ventral mesencephalic reticular formation and related Noradrenergic and serotonergic bundles in turning behaviour as investigated by means of kainate, 6 …
    650. Noradrenergic-mediated potentiation of acetylcholine release from the phrenic nerve: Evidence for presynaptic α1-adrenoceptor involvement
    651. Morphological evidence for 6-hydroxydopamine-induced sprouting of Noradrenergic neurons in the cerebellum
    652. Localization of central Noradrenergic mechanisms in cardiovascular regulation in rats
    653. Noradrenergic innervation of the heart in untreated and daunomycin-pretreated animals
    654. Cholinergic regulation of intracerebral Noradrenergic pathway-induced hypothalamic vasodilatation.
    655. Uptake of [3H]Dopamine into Dopaminergic and Noradrenergic Neurones of the Isolated Neurointermediate Lobe of the Rat Hypophysis. Effects of Desipramine and …
    656. Maternal methadone administration: Deficit in development of alpha-Noradrenergic responses in developing rat brain as assessed by norepinephrine stimulation of …
    657. Influence of diet palatability on the Noradrenergic feeding response in the rat
    658. 6-Hydroxydopamine, Noradrenergic reward, and schizophrenia
    659. Hydrophilic form of dopamine β-hydroxylase from purified Noradrenergic vesicles
    660. Agonist effects of. beta.-phenethylamines on the Noradrenergic cyclic adenosine 3′, 5′-monophosphate generating system in rat limbic forebrain. Stereoisomers of p …
    661. Effect of splenic nerve stimulation on the contents of noradrenaline, ATP and sulphomucopolysaccharides in Noradrenergic vesicle fractions from the cat spleen
    662. Electrophysiological changes at a central Noradrenergic synapse during thallium toxicosis
    663. Central Noradrenergic mechanisms in hypertension and in postural hypotension
    664. Vesicle populations and exocytosis in Noradrenergic terminals of human veins
    665. Neurotoxicity of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP 4) on Noradrenergic neurons is mimicked by its cyclic aziridinium derivative
    666. Differential sensitivity of hypothalamic dopaminergic and Noradrenergic neurones to pharmacological manipulation
    667. The time course of the development and persistence of the autoinhibitory effect in Noradrenergic transmission
    668. Evidence for an inhibitory dopaminergic and stimulatory Noradrenergic hypothalamic influence on PMS-induced ovulation in the immature rat. II. A pharmacological …
    669. Feeding response to regulatory challenges after 6-hydroxydopamine injection into the brain Noradrenergic pathways
    670. Noradrenergic action in the developing rat cerebellum: interaction between norepinephrine and γ-aminobutyric acid applied microiontophoretically to immature …
    671. Interaction of histamine H2-receptor blocking drugs with the Noradrenergic system in rat brain and heart
    672. The role of a Noradrenergic system in the antinociceptive effects of 4-aminopyridine in the rat.
    673. Intracisternal dose-response analysis of 6-hydroxydopamine-induced Noradrenergic sprouting in the neonatal rat cerebellum.
    674. Role of Noradrenergic nerves and adrenal medulla during the development of genetic and experimental hypertension in rats
    675. 6-Hydroxydopamine, Noradrenergic reward, and schizophrenia
    676. Effect of ECT on dopaminergic and Noradrenergic mechanisms: I. Effect on the behavioural changes induced by reserpine, a-methyl-p-tyrosine or amphetamine.
    677. The regulation of hippocampal cholinergic neurons by Noradrenergic mechanisms
    678. Evidence suggesting that DMI-induced resistance to extinction is not mediated by the dorsal Noradrenergic bundle
    679. The development of pre‐and postsynaptic components of the Noradrenergic system in the rat cerebellum
    680. Regulation of Noradrenergic receptor systems in brain that are coupled to adenylate cyclase
    681. Effects of Noradrenergic agonists and antagonists on growth hormone secretion under gamma-hydroxybutyrate narco-analgesia in the rat
    682. Central Noradrenergic neurons: identification, distribution and synaptic interactions with axons containing morphine-like peptides.
    683. Presynaptic muscarinic and α-adrenergic receptor blocking effect of atropine on the Noradrenergic neurones of the rabbit pulmonary artery
    684. Lesions of the ventral Noradrenergic bundle produce a naloxone-reversible antinociception and affect brain and pituitary pools of β-endorphin
    685. Inhibition of the Noradrenergic induction of pineal N-acetyltransferase by dibutyryl cyclic guanosine monophosphate and by ionophore X-537A
    686. ROLE OF THE NUCLEUS LOCUS COERULEUS IN SYMPATHETHIC AND CENTRAL Noradrenergic ACTIVATION AS REFLECTED BY CHANGES IN THE …
    687. Mechanism of the enhancement in transmitter release from central and peripheral Noradrenergic nerve terminals induced by the purified scorpion venom, tityustoxin
    688. Ventral Noradrenergic bundle “area” lesions producing reduced body weight and activity
    689. Investigations on the interaction of thyrotropin-releasing hormone (TRH) and MK-771 with central Noradrenergic mechanisms
    690. Effect of desipramine on Noradrenergic inhibition of amygdaloid evoked potential
    691. The functional role of the Noradrenergic neurons in the thermoregulatory circuits in mice
    692. Comparison of the effects of chronic chloroquine treatment and denervation on Noradrenergic mechanisms.
    693. Dopaminergic and Noradrenergic inhibition of hypothalamic self-stimulation: Differentiation of reward and performance effects
    694. The role of central serotoninergic and Noradrenergic neurons in the regulation of nyctohemeral rhythm of plasma thyrotropin
    695. High resolution radioautography of Noradrenergic axon terminals in the neocortex
    696. Noradrenergic neurones in the brain
    697. Effects of pretreatment with 6-hydroxydopamine or Noradrenergic receptor blockers on the clonidine-induced disruption of conditioned avoidance responding
    698. Noradrenergic modulation of REM sleep: Pharmacological evidence
    699. Fluorescence histochemical and ultrastructural observations on preterminal Noradrenergic axons following ligation or treatment with 6-hydroxydopamine.
    700. Noradrenergic mechanism of experimental cerebral vasospasm
    701. Central Noradrenergic neurons: studies on the mechanism of the in vivo activation of tyrosine hydroxylase
    702. Effects of amitriptyline, desipramine and mianserin on Noradrenergic transmission in the rat isolated right ventricle
    703. Labetalol blockade of central α-and β-Noradrenergic receptors in rat brain homogenates
    704. The operation of autoregulatory feedback loops in Noradrenergic transmission to cardiovascular effector tissues.
    705. Central action of narcotic analgesics. Part IV. Noradrenergic influences on the activity of analgesics in rats.
    706. Evidence for a Noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, α-dimethyl-m-tyramine (H 77/77) in rats
    707. Effect of lesions of the ventral Noradrenergic bundle on the two-way avoidance behavior in rats.
    708. Selective activation of Noradrenergic neurons in the brainstem and spinal cord of young spontaneously hypertensive rats
    709. On the mechanism of amphetamine-induced behavioural changes in the mouse. II. Effects of agents stimulating Noradrenergic receptors.
    710. Field potentials in primate locus coeruleus following stimulation of the dorsal Noradrenergic bundle
    711. Noradrenergic stimulation of the lateral hypothalamus as a reinforcement in T maze learning in rats
    712. The Noradrenergic locus coeruleus: behavioral effects of intracerebral injections, and a survey of its structure, function and pathology
    713. Evidence for Noradrenergic involvement in naloxone-induced stimulation of luteinizing hormone release in prepubertal female rats
    714. Regenerative sprouting of Noradrenergic terminals in the cerebellum
    715. Studies on the effect of lesions of the ventral Noradrenergic tract on the antinociceptive action of morphine
    716. … of the polychlorinated biphenyl preparation, Aroclor 1242, on color changes of the fiddler crab,Uca pugilator, by norepinephrine and drugs affecting Noradrenergic …
    717. A method for the measurement of growth of Noradrenergic axons in tissue culture and the effects of colchicine thereon
    718. Regenerative critical periods for locus coeruleus in post-natal rat pups following intracisternal 6-hydroxydopamine: a model of Noradrenergic development
    719. The effects of ketamine on Noradrenergic transmission and the response to noradrenaline in rat smooth muscle [proceedings]
    720. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central Noradrenergic and dopaminergic receptors
    721. Involvement of central Noradrenergic system in thyrotropin-releasing hormone-induced behavioral excitement in 6-OHDOPA-treated, infant rats
    722. Colchicine may interfere with the axonal transport of noradrenaline in the central Noradrenergic neurons
    723. Stress suppression of growth hormone secretion in the rat: effects of disruption of inhibitory Noradrenergic afferents to the median eminence
    724. Profound hypothermia in golden hamsters (Mesocricetus auratus) induced by serotonergic potentiating and Noradrenergic inhibiting drugs
    725. THE Noradrenergic SYSTEM AND THE DEVELOPING CEREBELLUM.
    726. Noradrenergic and serotonergic regulation of cholinergic activity in the rat hippocampus
    727. Possible correlation between Noradrenergic innervation in the cerebellum and jumping behavior in mice
    728. Modulation of Noradrenergic transmission by the presynaptic alpha-inhibitory feedback process in the rat heart [proceedings]
    729. Noradrenergic control of circadian rhythms in Cebus albifrons
    730. 6-Hydroxydopamine treatment diminishes Noradrenergic and pressor responses to angiotensin II in adrenalectomized ducks
    731. Noradrenergic drugs and affective disorders
    732. EFFECTS OF PROGESTERONE ON THE Noradrenergic SYSTEM OF RABBIT OVIDUCTS
    733. Central Noradrenergic regulation of cerebral blood flow
    734. Central dopaminergic and Noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
    735. The Noradrenergic innervation of the excretory ducts of the parotid, mandibular and sublingual glands in the rat
    736. Relation between destruction and sprouting of developing central Noradrenergic neurons after neurotoxic compounds
    737. Rewarding effect of Noradrenergic stimulation of the amygdala in food deprived rats
    738. The involvement of Noradrenergic nerves in the cardiovascular reflex responses to lower body negative pressure in the anaesthetised rabbit.
    739. The effect of Noradrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats.
    740. Uptake of H 3-5-hydroxytryptophan by Noradrenergic nerves in the mouse pancreas studied with electron microscopic autoradiography
    741. Dual Noradrenergic control of oxytocin release during the milk ejection reflex in the rat
    742. Opiate receptors localized presynaptically on dopaminergic and Noradrenergic neurons in brain: relevance to tolerance and dependence to opioids
    743. Regional characteristics of the Noradrenergic and cholinergic innervation of the vessels of the brain surface
    744. Cholinergic, dopaminergic, Noradrenergic, or glutaminergic stimulation ventral to the anterior septum does not specifically suppress defensive behavior
    745. (−)-[3H] Dihydroalprenolol binding in subcellular fractions of rat cortex following Noradrenergic denervation
    746. Immune lesions of central Noradrenergic neurons produced by dopamine β-hydroxylase (DBH) antibodies
    747. Effects of captopril on vascular Noradrenergic transmission during the development of two-kidney, one clip Goldblatt hypertension in rats.
    748. The effect of tranylcypromine on Noradrenergic nerve terminals in different brain regions
    749. Effect of stress on various characteristics of norepinephrine metabolism in central Noradrenergic neurons
    750. (3, 4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at Noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic …
    751. Do endogenous prostaglandins modulate Noradrenergic transmission in the rat isolated perfused vas deferens?
    752. Up-and Down-regulation of Noradrenergic Receptor Systems in Brain: Molecular Mechanisms and Physiological Significance
    753. Receptor dynamics: effect of repeated administration of desmethylimipramine on the Noradrenergic systems in rat brain.
    754. THE EFFECTS OF 6‐HYDROXYDOPAMINE OR (–)‐NORADRENALINE TREATMENT IN VITRO ON Noradrenergic TRANSMISSION IN THE RAT …
    755. Noradrenergic INFLUENCES ON SELECTIVE ATTENTION: INTERACTIONS WITH DEVELOPMENT.
    756. Inhibitory effect of tricyclic antidepressant drugs on spontaneous activity of Noradrenergic neurons-relation with blood and brain concentrations
    757. Noradrenergic supersensitivity in the rat vas deferens during barbital withdrawal
    758. Acute thyroid hormone increases Noradrenergic responsiveness of rat atria in vitro
    759. EFFECT OF DESTRUCTION OF Noradrenergic TERMINALS IN SPINAL CORD BY MICROINJECTION OF 6-HYDROXY-DOPAMINE INTO CAUDAL BULBAR …
    760. Psychotropic effects of a new beta Noradrenergic receptor blocking agent, acebutolol, in psychotics (author’s transl)
    761. Inhibitory presynaptic effects of hydralazine on Noradrenergic nerve terminals of the rat tail artery [proceedings]
    762. Pharmacology of central Noradrenergic receptors (author’s transl)
    763. INTERACTIONS BETWEEN Noradrenergic AND CHOLINERGIC SYSTEMS IN THE BRAIN
    764. Activation of central Noradrenergic and adrenergic neurons in young and adult spontaneously hypertensive rats
    765. Analysis of the role of central Noradrenergic structures in memory trace recall
    766. The in vitro and in vivo effects of vinca alkaloids on the Noradrenergic innervation of the vas deferens
    767. … between the effects of the memory neuromodulator arginine-vasopressin and the levels of activity of the serotonin-, dopamine-and Noradrenergic systems of the brain
    768. Noradrenergic signal transfer as a target of antidepressant therapy
    769. Enhanced responsiveness of α-Noradrenergic receptors following discrete electrolytic lesions of the nucleus locus coeruleus: A behavioral demonstration
    770. A glycoprotein fraction with modulator effect on Noradrenergic processes
    771. PHARMACOLOGICAL CHARACTERIZATION OF Noradrenergic RESPONSES IN RAT HIPPOCAMPUS: AN ELECTROPHYSIOLOGICAL STUDY.
    772. The anticonvulsant effect of neuroleptics: dependence on intact Noradrenergic transmission
    773. Rotational behavior produced by unilateral ventral Noradrenergic bundle lesions: Evidence for a Noradrenergic-dopaminergic interaction in the brain
    774. An examination of the action of tetrabenazine on peripheral Noradrenergic neurones [proceedings]
    775. Small Noradrenergic vesicles from vas deferens of castrated rats: a comparison with large Noradrenergic vesicles
    776. REGULATION OF CATECHOLAMINE BIOSYNTHESIS IN CENTRAL Noradrenergic NEURONS.
    777. Functional role of Noradrenergic neurons in the hypothermic effect of apomorphine and other dopaminomimetics
    778. Proceedings: Loss of Noradrenergic and dopaminergic terminals in the chronically isolated cerebral cortex of the cat.
    779. The role of central Noradrenergic and dopaminergic neurons in the control of TRH-TSH secretion
    780. The integrity of the Noradrenergic innervation of the cardiovascular system in genetically dystrophic hamsters.
    781. Noradrenergic TRANSMISSION IN ISOLATED GUINEA‐PIG INTESTINE FOLLOWING IN VIVO ADMINISTRATION OF ANTIBODIES TO DOPAMINE β …
    782. Thermoregulatory pathways from cutaneous thermoreceptors to the hypothalamus via Noradrenergic and serotonergic pontine regions